A novel mechanism of action of HER2 targeted immunotherapy is explained by inhibition of NRF2 function in ovarian cancer cells

por Khalil, Hilal S., Langdon, Simon P., Goltsov, Alexey, Soininen, Tero, Harrison, David J., Bown, James, Deeni, Yusuf Y.
Publicado 2016

Systems Analysis of Drug-Induced Receptor Tyrosine Kinase Reprogramming Following Targeted Mono- and Combination Anti-Cancer Therapy

por Goltsov, Alexey, Deeni, Yusuf, Khalil, Hilal S., Soininen, Tero, Kyriakidis, Stylianos, Hu, Huizhong, Langdon, Simon P., Harrison, David J., Bown, James
Publicado 2014